SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses, announced today that it has named John Micek III to its board of directors. Mr. Micek was also appointed to each of the Company’s three standing committees as well as being appointed as the chair of Jaguar’s Audit Committee.
